New and recently funded Medical Startups
1
Country: USA | Funding: $225M
Solstice Oncology is a clinical stage immuno-oncology company. The company licensed the Fc-enhanced cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody, called porustobart, from China's Harbour BioMed to develop and commercialize the drug outside of China. The company has already taken porustobart into phase 2 development for microsatellite stable (MSS) stage II and III colon cancer.
Solstice Oncology is a clinical stage immuno-oncology company. The company licensed the Fc-enhanced cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) antibody, called porustobart, from China's Harbour BioMed to develop and commercialize the drug outside of China. The company has already taken porustobart into phase 2 development for microsatellite stable (MSS) stage II and III colon cancer.
2
Country: USA
PeriSlayer is an AI perimenopause tracking app. Women log hot flashes, sleep, mood, energy and cycles in seconds, and the app surfaces patterns across those entries, then turns them into a doctor-ready report to bring to an appointment. It also includes a private community, mood playlists and an open-level Pilates program. PeriSlayer is a wellness companion, not a medical device.
PeriSlayer is an AI perimenopause tracking app. Women log hot flashes, sleep, mood, energy and cycles in seconds, and the app surfaces patterns across those entries, then turns them into a doctor-ready report to bring to an appointment. It also includes a private community, mood playlists and an open-level Pilates program. PeriSlayer is a wellness companion, not a medical device.
3
Country: Australia
WeGuide is an all-in-one patient engagement platform managing the complete patient journey for clinicians and researchers. With modules like eConsent, surveys, wearable data integration, and telehealth, the platform transforms protocols into personalised digital interventions.
WeGuide is an all-in-one patient engagement platform managing the complete patient journey for clinicians and researchers. With modules like eConsent, surveys, wearable data integration, and telehealth, the platform transforms protocols into personalised digital interventions.
4
Country: United Arab Emirates | Funding: $2M
Dawraty builds an AI learning platform for healthcare education, professional certification, and exam preparation. Its customers include universities, medical colleges, hospital groups, and government training bodies, which use the platform to deliver and track accredited learning in Arabic and English.
Dawraty builds an AI learning platform for healthcare education, professional certification, and exam preparation. Its customers include universities, medical colleges, hospital groups, and government training bodies, which use the platform to deliver and track accredited learning in Arabic and English.
5
Country: USA | Funding: $59M
Evvy provides vaginal health testing, clinical care, and products focused on understanding and supporting the vaginal microbiome.
Evvy provides vaginal health testing, clinical care, and products focused on understanding and supporting the vaginal microbiome.
6
Country: USA | Funding: $396M
Angle Health is an AI-powered health insurance provider for small business. It offers employers greater flexibility and options for insuring and providing benefits to their employees. It uses machine learning to automatically customize benefits to meet the needs of every employee. Using the proprietary Quote to Card technology and Benefit Builder platform, the company offers fast quotes with fixed funding, customized plans and integrated points solutions. Angle integrates with over 100 payroll, HRIS and benefits administration platforms, allowing us to connect employers with their current level of tool usage.
Angle Health is an AI-powered health insurance provider for small business. It offers employers greater flexibility and options for insuring and providing benefits to their employees. It uses machine learning to automatically customize benefits to meet the needs of every employee. Using the proprietary Quote to Card technology and Benefit Builder platform, the company offers fast quotes with fixed funding, customized plans and integrated points solutions. Angle integrates with over 100 payroll, HRIS and benefits administration platforms, allowing us to connect employers with their current level of tool usage.
7
Country: USA | Funding: $158M
Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, based on Linsitinib licensed by the startup from Astellas. Linsitinib is a tyrosine kinase inhibitor (TKI) designed to block the insulin-like growth factor 1 receptor (IGF-1R). This receptor has been shown to talk to other receptors on the surface of cells behind the eye as well as immune cells, and its overexpression or activation in these cells is what drives the inflammation, swelling and tissue damage characteristic of TED.
Sling Therapeutics develops pharmaceutical treatments for thyroid eye disease, based on Linsitinib licensed by the startup from Astellas. Linsitinib is a tyrosine kinase inhibitor (TKI) designed to block the insulin-like growth factor 1 receptor (IGF-1R). This receptor has been shown to talk to other receptors on the surface of cells behind the eye as well as immune cells, and its overexpression or activation in these cells is what drives the inflammation, swelling and tissue damage characteristic of TED.
8
Country: USA
QuickIntell develops AI software for healthcare revenue cycle operations. Its workflows support eligibility verification, prior authorization, coding assistance, claims, denials and accounts-receivable follow-up, with human review and audit trails. The platform serves practices, hospitals and RCM companies.
QuickIntell develops AI software for healthcare revenue cycle operations. Its workflows support eligibility verification, prior authorization, coding assistance, claims, denials and accounts-receivable follow-up, with human review and audit trails. The platform serves practices, hospitals and RCM companies.
9
Country: USA | Funding: $24M
Optura operates enterprise healthcare platform for ROAI. It unites C-suite decision-making under a proven methodology and healthcare-trained technology. The ROAI framework projects resources and revenue so that healthcare institutions could prioritize use cases based on value to demonstrate returns. Every use case can be activated with the Optura AI platform to turn strategy into action and action into returns on investment.
Optura operates enterprise healthcare platform for ROAI. It unites C-suite decision-making under a proven methodology and healthcare-trained technology. The ROAI framework projects resources and revenue so that healthcare institutions could prioritize use cases based on value to demonstrate returns. Every use case can be activated with the Optura AI platform to turn strategy into action and action into returns on investment.
10
Country: Israel | Funding: $11M
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.
